Join the Anesthetic Adjunct group to help and get support from people like you.
Anesthetic Adjunct News
Head Injuries Are a Growing Risk for Anesthesiologists, Experts Warn
SUNDAY, April 27, 2025 — One moment, Dr. Cornelius Sullivan was standing over a patient during surgery. The next, he woke up in an ambulance on the way to the emergency room. The anesthesiologist had ...
AAOS: Stopping GLP-1 RAs 14 Days Before Surgery Can Minimize Complications
TUESDAY, March 11, 2025 – Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study...
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia
THURSDAY, March 6, 2025 – Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a study published...
Number of Anesthesiology Residents Applying to Pain Medicine Fellowships Decreasing
WEDNESDAY, Feb. 5, 2025 – The number of anesthesiology residents applying to pain medicine decreased 45 percent from 2019 to 2023, according to a study published in the January issue of PAIN...
Guidelines Developed to Address Infections Tied to Regional Anesthesia
THURSDAY, Jan. 30, 2025 – In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and published online Jan. 20 in Regional Anesthesia & Pain Medicine,...
Insurer Anthem Rescinds Anesthesia Policy Change After Backlash
FRIDAY, Dec. 5, 2024 – After facing weeks of pushback, health insurer Anthem Blue Cross Blue Shield said Thursday it will not go ahead with a policy change that would have limited reimbursements for...
1 in 3 Surgery Patients Suffer Complications
THURSDAY, Nov. 14, 2024 – More than a third of surgical patients develop complications as a result of their procedure, a new study shows. About 38% of adult patients suffer an adverse event during...
FDA Medwatch Alert: Atracurium Besylate Injection by Sagent Pharmaceuticals: Recall - Potential Impact on Product Sterility
ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of...
FDA Medwatch Alert: Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected
ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of three lots of Vecuronium Bromide for Injection 10mg (NDC number 25021-657-10) manufactured by Mustafa Nevzat Ilac...